reLeaph

20 million people in the US alone suffer from severe chronic pain.
Caught between the actual pain and the side effects caused by pain medication, these patients are severely impacted in their professional as well as in their private lives.

reLeaph is a wearable medical device that offers an effective alternative to traditional pain management strategies and provides actual comfort by eliminating pain without leading the patients into chemical dependency and without causing any other disruptive side effects.

The reLeaph Pain Cancellation Device utilizes the principle implemented in noise cancellation devices: destructive interference.

reLeaph’s adaptive algorithms are designed to analyze the waveform of a nerve signal, then generate awave that represents the inverted  phase of the original signal. This inverted wave is then amplified and a transducer creates a signal directly proportional to the amplitude of the original waveform; thereby effectively eliminating the original pain signal.

Gründer:

  • Andreas Peneder
  • Johannes Woeckinger

Fakten

  • Firmenname

    reLeaph
  • Website

    -
  • CEO

    Andreas Peneder
  • tech2b Projekt

    2016
  • Branche

    Medical Device
  • Mitarbeiter

    -
  • Märkte

    USA

Kontakt

releaph Labs Austria
Hafenstrasse 47-51
4020 Linz
T -
E Info@releaph.com